Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach

PURPOSE: Hyperthermic intraperitoneal chemotherapy (HIPEC) has been considered a promising treatment option for advanced or recurrent ovarian cancer, but there is no clear evidence based on randomized controlled trials to advocate this approach as a standard therapy. In this study, we aim to present...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Thales Paulo, Carneiro, Vandré Cabral G, Tancredi, Rodrigo, Teles, Ana Ligia Bezerra, Badiglian-Filho, Levon, Leão, Cristiano Souza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732565/
https://www.ncbi.nlm.nih.gov/pubmed/29263704
http://dx.doi.org/10.2147/CMAR.S153327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732565/
https://www.ncbi.nlm.nih.gov/pubmed/29263704
http://dx.doi.org/10.2147/CMAR.S153327

Ejemplares similares